Latest Releases
U.S. Senator Tina Smith Applauds Senate Passage of Her Bipartisan Bill to Help Small Businesses Access Capital, Create Jobs in Rural America
WASHINGTON – U.S. Senator Tina Smith (D-MN) applauded the Senate’s passage of her bipartisan Expanding Access to Capital for Rural Job Creators Act. The legislation, which is co-led by Senator John Kennedy (R-LA), would help eliminate hurdles small businesses in rural areas disproportionately face when they try to access capital. “Access to capital is essential to the economic health and growth of rural communities in Minnesota and across the country,” said Sen. Smith. “Rural small businesses often face disproportionate obstacles when trying to secure capital to develop and grow their businesses. This legislation would help rural small businesses overcome these hurdles and strengthen our rural economies.” Access to capital is critical for starting and expanding rural small businesses, which often face a disproportionate number of obstacles when seeking capital investment. This bipartisan legislation, the Expanding Access to Capital for Rural Job Creators Act, would require the Securities and Exchange Commission to submit annual reports on the unique challenges small businesses in rural areas face when trying to secure capital. The report would outline roadblocks and identify solutions to ensure rural small businesses, and the local economies they support, are able to develop and grow. Senators Gary Peters (D-MI), Raphael Warnock (D-GA), Shelley Moore Capito (R-WV) and Jacky Rosen (D-NV) also cosponsored the legislation.
U.S. Senator Tina Smith’s Legislation to Tackle Drug Shortages, Improve Public Health Preparedness Advances Through Key Committee
WASHINGTON, D.C. [8.4.23] –U.S. Senator Tina Smith (D-MN) announced that two of her legislative priorities, aimed at addressing drug shortages and improving public health preparedness, took a major step forward. “Drug shortages are hurting patients, pharmacists, and physicians across the country,” said Senator Smith. “I have heard directly from Minnesotans who are facing shortages of ADHD medications like Adderall, cancer-fighting drugs for chemotherapy, among other things. These drug shortages can be life-threatening, and I’ve made it a priority to tackle this problem. In addition, I’m focused on ensuring we are prepared for future public health threats. My bipartisan legislation will improve the FDA’s responsiveness when medication demand outpaces the supply, and help improve our ability to rapidly develop and distribute diagnostic tests in the event of a disease outbreak. I’m glad to see these priorities included in this important legislation.” The Pandemic and All-Hazards Preparedness and Response Act is essential legislation that reauthorizes key public health and emergency preparedness programs. Current funding expires on September 30th. Millions of Americans have been affected by shortages of chemotherapy drugs, commonly-used antibiotics, pediatric formulations of medications like ibuprofen, and other essential drugs. Pieces of Senator Smith’s legislation, which have been included in the reauthorization, will help address these shortages and bolster public health preparedness. Senator Smith’s provisions include:
Bill to Ensure Back Pay for Federal Contractor Employees Secures Bipartisan Support
WASHINGTON, D.C. [02/01/19]—Today, legislation to secure back pay for the federal contractor employees who went without pay during the recent government shutdown garnered bipartisan support thanks to Senator Susan Collins (R-Maine) cosponsoring a bill led by Senator Tina Smith (D-Minn.). “I want to thank my colleague Senator Collins for supporting the effort to make sure Americans who work shoulder to shoulder with federal employees receive back pay,” said Sen. Smith. “These are people who are often invisible—working in cafeterias, cleaning offices after others go home, and keeping our buildings safe—and they deserve back pay. This bill is trying to fix that, and
U.S. Senator Tina Smith, Senate Democrats Urge DeVos to Listen to Students and Survivors of Sexual Assault, Start Over on Title IX Rule
WASHINGTON, D.C. [02/04/2019]–U.S. Senator Tina Smith (D-Minn.) joined her colleagues—led by Senate Education Committee ranking member Senator Patty Murray(D-Wash.)—in urging Education Secretary Betsy DeVos to rescind proposed Title IX changes and to instead draft a rule that truly addresses sexual assault in schools, colleges, and universities in Minnesota and across the country. Since Secretary DeVos announced her proposed rule, students, survivors, advocates, and colleges around the country have fiercely opposed her proposal, which would weaken protections for students and allow schools to shirk their responsibility to keep students safe. “We urge you to listen to students, schools, and survivors across this country,” the Senators wrote. “Clearly, harassment and assault are
U.S. Senator Tina Smith’s Statement on President Trump’s State of the Union Address
WASHINGTON, D.C. [02/05/2019]—This evening, U.S. Senator Tina Smith (D-Minn.) released the following statement in response to President Trump’s State of the Union Address. “I grew up with my mom always saying something that I think a lot of other Americans heard growing up—that ‘actions speak louder than words.’ We heard the President bring up bipartisanship tonight, and wouldn’t it be great if he lives up to his words,” said Sen. Smith. “His actions need to match what he shared with all of us, and one place I hope we can gain bipartisan support is my bill to help federal contract workers get
U.S. Senator Tina Smith Continues Fight to Lower Prescription Drug Prices By Backing Bipartisan Legislation to Bring Generics to Market
Senator Says Bipartisan Legislation Would Combat Brand-Name Pharmaceutical Companies Unfairly Blocking Lower-Cost Generic Drugs WASHINGTON, D.C [02/06/2019]—This week, U.S. Senator Tina Smith (D-Minn.) continued one of her top health care priorities—lowering the skyrocketing costs of prescription drugs—by supporting bipartisan legislation led by Sen. Patrick Leahy (D-Vt.) to stop brand-name pharmaceutical companies from blocking lower-cost generic drugs to market. The Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act, which is also supported by Minnesota Senator Amy Klobuchar (D-Minn.), would deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace. “The amount of money that Americans pay for medications
English